Corbus Pharmaceuticals - CRBP Short Interest Ratio & Short Volume

Short interest is the volume of Corbus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 146,100 shares of CRBP short. 3.52% of Corbus Pharmaceuticals' shares are currently sold short. Learn More on Corbus Pharmaceuticals' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corbus Pharmaceuticals: Group One Trading L.P., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.52% of Corbus Pharmaceuticals' floating shares are currently sold short.

Corbus Pharmaceuticals saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 146,100 shares, a decrease of 1.7% from the previous total of 148,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Corbus Pharmaceuticals currently has issued a total of 4,170,000 shares. Some of Corbus Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corbus Pharmaceuticals currently has a public float of 4,150,000 shares.

3.52% of Corbus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corbus Pharmaceuticals: Lumos Pharma, Inc. (3.87%), Neoleukin Therapeutics, Inc. (0.72%), Satsuma Pharmaceuticals, Inc. (0.94%), Cumberland Pharmaceuticals Inc. (0.34%), Kala Pharmaceuticals, Inc. (18.45%), Impel Pharmaceuticals Inc. (3.09%), Lipocine Inc. (1.50%), RenovoRx, Inc. (0.12%), TFF Pharmaceuticals, Inc. (0.67%), and Moleculin Biotech, Inc. (0.15%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling CRBP is an investing strategy that aims to generate trading profit from Corbus Pharmaceuticals as its price is falling. CRBP shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Corbus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBP, twice per month. The most recent reporting period available is March, 15 2023.